H. Shimada et al., Terminology and morphologic criteria of neuroblastic tumors - Recommendations by the International Neuroblastoma Pathology Committee, CANCER, 86(2), 1999, pp. 349-363
BACKGROUND, As part of the international cooperative effort to develop a co
mplete set of International Neuroblastoma Risk Groups, the International Ne
uroblastoma Pathology Committee (INPC) initialed activities in 1994 to devi
se a morphologic classification of neuroblastic tumors (NTs; neuroblastoma,
ganglioneuroblastoma, and ganglioneuroma).
METHODS. Six member pathologists (H.S., I.M.A., L.P.D., J.H., V.VJ., and B.
R.) discussed and defined morphologically based classifications (Shimada cl
assification; risk group and modified risk group proposed by Joshi et al.)
on the basis of a review of 227 cases, using various pathologic characteris
tics of the NTs. The classification-grading system was evaluated for progno
stic significance and biologic relevance.
RESULTS. The INPC has adopted a prognostic system modeled on one proposed b
y Shimada et al. It is an age-linked classification dependent on the differ
entiation grade of the neuroblasts, their cellular turnover index, and the
presence or absence of Schwannian stromal development. Based on morphologic
criteria defined in this article, NTs were classified into four categories
and their subtypes: 1) neuroblastoma (Schwannian stroma-poor), undifferent
iated, poorly differentiated, and differentiating; 2) ganglioneuroblastoma,
intermixed (Schwannian stroma-rich); 3) ganglioneuroma (Schwannian stroma-
dominant), maturing and mature; and 4) ganglioneuroblastoma, nodular (compo
site Schwannian stroma-rich/stroma-dominant and stroma-poor). Specific feat
ures, such as the mitosis-karyorrhexis index, the mitotic rate, and calcifi
cation, were also included to allow the prognostic significance of the clas
sification to be tested. Recommendations are made regarding the surgical ma
terials to use for an optimal pathobiologic assessment and the practical ha
ndling of samples.
CONCLUSIONS. The current article covers the essentials and important points
regarding the histopathologic evaluation of NTs. Using the morphologic cri
teria described herein, the INPC is proposing the International Neuroblasto
ma Pathology Classification. It is reported in a companion article in this
issue (Cancer 1999;86:363-71). Cancer 1999;86:349-63. (C) 1999 American Can
cer Society.